Unjoni Ewropea - Malti - EMA (European Medicines Agency)

shionogi b.v. - naldemedine tosilate - stitikezza - mediċini għall-istitikezza, periferali opioid ta ' l-antagonisti tar-riċettur - rizmoic huwa indikat għat-trattament ta ' stitikezza ikkaġunata minħabba opjojdi (oic) fil-pazjenti adulti li jkunu diġà ġew ittrattati bl-lassattiv.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - imipenem monohydrate, cilastatin tas-sodju, relebactam monohydrate - gram-negattivi infezzjonijiet tal-batterji - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 u 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4, u 5. għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu xieraq ta ' sustanzi antibatteriċi.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

biocryst ireland limited - berotralstat dihydrochloride - angioedemas, ereditarji - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - aġenti antineoplastiċi - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.